Clinical Trial Details

EORTC-1820-CLTG

Back to Clinical Trials Database

Open-Label, phase II, Multi-Center, study of Anti-CCR4 Monoclonal Antibody (mogamulizumab) Plus Total Skin Electron Beam therapy (TSEB) in patients with stage IB-IIB Cutaneous T-Cell Lymphoma (MOGAT)

Study documentation

Trial Status Recruiting
Dates Date of activation: 21-Feb-2023
Data management at EORTC Yes
Design Phase 2
Not randomized / N.A.
Targeted Sample size EORTC Groups: 43 - All Groups: 43
Treatment Radiotherapy, Drug
Mogamulizumab
Study Staff Pablo Luis Ortiz Romero (Study Coordinator) , Hospital Universitario 12 De Octubre, Madrid
Stephanie Antunes (Clinical Scientist) , EORTC Headquarters, Brussels
Jessica Berger (Clinical Research Associate/Monitor) , EORTC Headquarters, Brussels
Emanuel Buhrer (Project Physician) , EORTC Headquarters, Brussels
Jose Casas (TR Scientist) , EORTC Headquarters, Brussels
Enrico Clementel (QART Manager) , EORTC Headquarters, Brussels
Coreen Corning (QART Manager) , EORTC Headquarters, Brussels
Richard Cowan (Study Co-Coordinator) , The Christie NHS Foundation Trust, Manchester
Carolina Fernandes (Clinical Operations Manager) , EORTC Headquarters, Brussels
Claire Gandilhon (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Amaya Gonzalez (Clinical Research Associate/Monitor) , EORTC Headquarters, Brussels
Jammbe Musoro (Statistician) , EORTC Headquarters, Brussels
Jan Nicolay (Study Co-Coordinator) , UniversitaetsMedizin Mannheim, Mannheim
Davide Passariello (Project Manager) , EORTC Headquarters, Brussels
Davide Passariello (Project Manager) , EORTC Headquarters, Brussels
Sandrine Rivrain (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Nathalie Ropson (Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Luiza Souza (QART Manager) , EORTC Headquarters, Brussels
Tsvetelina Stefanova (Data Manager) , EORTC Headquarters, Brussels
Katheline Vander Heggen (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Tim Verbiest (Study Designer) , EORTC Headquarters, Brussels
Christine de Balincourt (Lead CRA) , EORTC Headquarters, Brussels
Type of cancer Primary Cutaneous Lymphomas
Participating groups EORTC Cutaneous Lymphoma Tumor Group
Recruiting centers APHP Nord - Univ De Paris Cite - Hop. Saint Louis (Paris, France)
Athens University - Attikon University General Hospital (Athens, Greece)
Azienda Ospedaliera Città della Salute e della Scienza di Torino - Ospedale San Lazzaro (Torino, Italy)
Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia (Brescia, Italy)
Hospital De La Santa Creu I Sant Pau (Barcelona, Spain)
Hospital Universitario 12 De Octubre (Madrid, Spain)
Hospital Universitario Puerta De Hierro (Majadahonda, Spain)
Muehlenkreiskliniken Johannes Wesling Klinikum Minden (Minden, Germany)
Rigshospitalet (Copenhagen, Denmark)
The Christie NHS Foundation Trust (Manchester, United Kingdom)
UHB-Queen Elizabeth Medical Centre (Birmingham, United Kingdom)
UniversitaetsMedizin Mannheim (Mannheim, Germany)
Centers to be activated CHU de Bordeaux - Groupe Hospitalier Saint-Andre - Hopital Saint-Andre (BORDEAUX CEDEX, France)
Charite - Universitaetsmedizin Berlin - Campus Mitte (Berlin, Germany)
HELIOS Klinikum Krefeld-Staedt Krankenanstalten Krefeld (Krefeld, Germany)
Ludwig-Maximilians-Universitaet Muenchen - Klinik und Poliklinik für Dermatologie und Allergologie - Innenstadt (Muenchen, Germany)
Universitaetsklinikum Schleswig-Holstein - Campus Kiel (Kiel, Germany)
Protocol summary http://clinicaltrials.gov/study/NCT04128072
NCT number NCT04128072
EudraCT 2019-004566-17
Financial Support Kyowa Kirin